Pharma Stocks
-
A Fresh Look at Ascendis Pharma (NasdaqGS:ASND) Valuation as Shareholder Returns Turn Positive
Ascendis Pharma (NasdaqGS:ASND) has seen its share price fluctuate recently, but returns over the past month and 3 months are…
Read More » -
A Look at Ionis Pharmaceuticals’s Valuation as Zilganersen Trial Delivers Landmark Results for Alexander Disease
Ionis Pharmaceuticals (IONS) reported positive topline results from its pivotal trial of zilganersen for Alexander disease, showing clear disease stabilization.…
Read More » -
Teva (NYSE:TEVA) Valuation in Focus as Analyst Upgrades and Innovation Strategy Boost Outlook
Teva Pharmaceutical Industries (NYSE:TEVA) stock has caught fresh attention as several analysts recently raised earnings estimates, citing encouraging data from…
Read More » -
Grippewelle Concerns Trigger Surge in Pharma Stocks as Germany Prepares
Germany’s flu season, known as “grippewelle,” is drawing heightened attention amidst predictions of a severe outbreak. This has spurred increased…
Read More » -
Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best biotech stocks to buy. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) participated in the Bank…
Read More » -
AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
Shares of AstraZeneca (NASDAQ: AZN) have jumped more than 10% this week. On Monday, the British drugmaker reported positive results…
Read More » -
Revenues Not Telling The Story For Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) After Shares Rise 28%
Despite an already strong run, Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares have been powering on, with a gain of 28% in…
Read More » -
Pharma Mar (BME:PHM) rises 8.0% this week, taking one-year gains to 106%
Unfortunately, investing is risky – companies can and do go bankrupt. But if you pick the right business to buy…
Read More » -
Danaher (DHR) Surges as Pharma Tariffs to Benefit Firm
We recently published 11 Stocks Crushing Wall Street With Whopping Gains. Danaher Corp. (NYSE:DHR) is one of the top performers…
Read More » -
GSK’s $30B US Gamble Sends Pharma Stocks Soaring After Trump Pricing Deal
This article first appeared on GuruFocus. GSK Plc (NYSE:GSK) is leaning harder into the United States, with outgoing CEO Emma…
Read More »